相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Omicron Variant (B.1.1.529): Infectivity, Vaccine Breakthrough, and Antibody Resistance
Jiahui Chen et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2022)
Spike mutation D614G alters SARS-CoV-2 fitness
Jessica A. Plante et al.
NATURE (2021)
Crystal structure of SARS-CoV-2 papain-like protease
Xiaopan Gao et al.
ACTA PHARMACEUTICA SINICA B (2021)
Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69-V70, France, August to December 2020
Antonin Bal et al.
EUROSURVEILLANCE (2021)
Therapeutic targets and potential agents for the treatment of COVID-19
Yinuo Wu et al.
MEDICINAL RESEARCH REVIEWS (2021)
The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery
Ziyang Fu et al.
NATURE COMMUNICATIONS (2021)
Perspective on therapeutic and diagnostic potential of camel nanobodies for coronavirus disease-19 (COVID-19)
Salma Bessalah et al.
3 BIOTECH (2021)
In Silico Elucidation of Potent Inhibitors and Rational Drug Design against SARS-CoV-2 Papain-like Protease
Kamonpan Sanachai et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2021)
Immunogenicity Risk Profile of Nanobodies
Chloe Ackaert et al.
FRONTIERS IN IMMUNOLOGY (2021)
Inhibition of interferon-stimulated gene 15 and lysine 48-linked ubiquitin binding to the SARS-CoV-2 papain-like protease by small molecules: In silico studies
Eleni Pitsillou et al.
CHEMICAL PHYSICS LETTERS (2021)
Interactions between SARS coronavirus 2 papain-like protease and immune system: A potential drug target for the treatment of COVID-19
Shahab Mahmoudvand et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2021)
Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodies
Lee A. Armstrong et al.
PLOS ONE (2021)
Emerging coronaviruses: Genome structure, replication, and pathogenesis
Yu Chen et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Characterization and Noncovalent Inhibition of the Deubiquitinase and delSGylase Activity of SARS-CoV-2 Papain-Like Protease
Brendan T. Freitas et al.
ACS INFECTIOUS DISEASES (2020)
The outbreak of Coronavirus Disease 2019 (COVID-19)—An emerging global health threat
Shajeea Arshad Ali et al.
Journal of Infection and Public Health (2020)
Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity
Donghyuk Shin et al.
NATURE (2020)
Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti-COVID-19 drug design
Wioletta Rut et al.
SCIENCE ADVANCES (2020)
Papain-Like Proteases as Coronaviral Drug Targets: Current Inhibitors, Opportunities, and Limitations
Anastasiia I. Petushkova et al.
PHARMACEUTICALS (2020)
Synthesis of a HyCoSuL peptide substrate library to dissect protease substrate specificity
Marcin Poreba et al.
NATURE PROTOCOLS (2017)
The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds
Yahira M. Baez-Santos et al.
ANTIVIRAL RESEARCH (2015)
A general protocol for the generation of Nanobodies for structural biology
Els Pardon et al.
NATURE PROTOCOLS (2014)
One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities
Lorenzo Subissi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Nidovirus papain-like proteases: Multifunctional enzymes with protease, deubiquitinating and delSGylating activities
Anna M. Mielech et al.
VIRUS RESEARCH (2014)
The Ubiquitin-Conjugating System: Multiple Roles in Viral Replication and Infection
Arianna Calistri et al.
CELLS (2014)
Virus-encoded proteinases and proteolytic processing in the Nidovirales
J Ziebuhr et al.
JOURNAL OF GENERAL VIROLOGY (2000)